Volume 3,Issue 7
乳腺癌肺转移瘤合并原发性肺癌：一例病例报道
在临床实践中乳腺癌肺转移瘤同时合并原发性肺癌的情况极为罕见，目前治疗方式缺乏相应的循证医学证据。本案例报道了一例55岁中年女性患者，既往8年前因“右侧乳腺浸润性导管癌”而接受右侧乳腺癌根治术，术后接受了规范的化放疗和内分泌治疗；今患者因“右肺上叶肿物（两病灶）”而接受3D胸腔镜下右肺上叶切除术联合系统性纵隔内淋巴结清扫术。术后病理学检查显示一病灶为乳腺癌肺转移瘤、另一病灶为肺原发浸润性腺癌。本案例追溯了患者整个诊治过程，综合运用影像、免疫组化和分子病理检测等手段，多维度的鉴别了右肺上叶多个病灶的分子遗传特征及来源，进而能够为临床治疗提供更为精确的指导，优化治疗方案，提高治疗效果。
[1]Kurniawan BN, Ferianto D, Pieter J Jr. Evaluation of breast cancer metastasis and mortality rates based on molecular subtype: A description study. Breast Dis. 2022. 41(1): 427-432.
[2]Smid M, Wang Y, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008. 68(9): 3108-14.
[3]Dan Z, Cao H, He X, et al. A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer. Theranostics. 2016. 6(3): 435-45.
[4]Tao Z, Li T, Feng Z, et al. Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. Front Oncol. 2020. 10: 1023.
[5]Oliveira AM, Ross JS, Fletcher JA. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol. 2005. 124 Suppl: S16-28.
[6]Mehdi A, Attias M, Arakelian A, Piccirillo CA, Szyf M, Rabbani SA. Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor
Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone. Cancers (Basel). 2022. 15(1): 48.
[7]Nishiyama N, Iwata T, Nagano K, et al. Lung metastases from various malignancies combined with primary lung cancer. Gen Thorac Cardiovasc Surg. 2010. 58(10): 538-41.
[8]Shih J, Bashir B, Gustafson KS, et al. Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung
Primary. J Natl Compr Canc Netw. 2015. 13(8): 947-52.
[9]Wang W, Belosay A, Yang X, et al. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells. Clin Exp
Metastasis. 2016. 33(5): 475-85.
[10]Fuke A, Tabei I, Okamoto T, Takeyama H. Complete remission from peritoneal metastasis of late recurrent breast cancer by endocrine therapy: a case report. Surg Case
Rep. 2020. 6(1): 313.
[11]de Baère T, Aupérin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.
Ann Oncol. 2015. 26(5): 987-991.
[12]Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiolo
gy. 2011. 261(2): 643-51.
[13]de Baere T, Tselikas L, Woodrum D, et al. Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis
at 1 Year. J Thorac Oncol. 2015. 10(10): 1468-74.
[14]Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011. 8(6): 378-82.